|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS11371|
DNA Sequencing Market Overview
The global DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2023). This is attributed to the extensive use of consumables for sample preparation, cluster generation, and other processes during the course of experiments.
DNA sequencing make use of various technological platforms for fragmentation and sequencing studies. These technological platforms include sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule-real-time sequencing, chain termination sequencing, and nanopore sequencing. Sequencing by synthesis is the most widely used platform in sequencing protocols and is the largest contributor to the DNA sequencing market, on the basis of product type. The category is also anticipated to witness fastest growth in demand, during the forecast period.
The DNA sequencing market finds application in biomarker and cancer, diagnostics, reproductive health, personalized medicine, and forensics. The latest technological innovations have highly increased sequencing speed, while reducing both the cost of sequencing, and protocol steps. These factors have led to the preference of the DNA sequencing technology for the study of biomarkers.
The end users in market include academic & government research institutes, pharmaceutical companies, biotechnology companies, hospitals & clinics. Sequencing is widely used in academic and government research institute due to the rise of genomics, transcriptomics, and proteomics research.
Globally, North America holds the largest share in the global market, mainly due to factors such as the presence of large number of academic and research institutes, and availability of technologically advanced products, and presence of major players in the region. Conversely, Asia-Pacific is expected to witness the fastest growth in demand during forecast period. The major factors driving the market demand in Asia-Pacific are increasing awareness about DNA sequencing, rise in the adoption of advanced technology for clinical applications.
DNA Sequencing Market Dynamics
The key trends observed in the DNA sequencing industry are surge in clinical assessment through personalized genomics, increase in oncological research, demand for easy and fast clinical diagnosis, and adoption of high throughput technology.
Various factors leading to the growth of the DNA sequencing industry include the rise in technological advancements, increase in collaborations & partnerships of key players, and global increase in genome mapping programs. Additionally, rise in R&D investment also enhances the growth of the market and provides lucrative opportunities to the key players. Some of the challenges hindering the growth of the market are concerns related to the accuracy & standardization, along with the ethical & legal limitations posed with DNA sequencing.
The DNA sequencing industry provides immense opportunities for the new players to grow, due to the eminence of latest innovative technology in the market. Subsequently, the key players are also exploring opportunities by leveraging their precedence in technological advancement. The advent of next generation DNA sequencing (NGS) also provides opportunities for the market players to grow in the future.
DNA Sequencing Market Competitive Landscape
The growing collaborations and partnerships among key players is expected to increase their market share in the coming years. For instance, in April 2017, Genome Diagnostics B.V. (GenDx) signed a global reseller agreement with Thermo Fisher Scientific, Inc. next-generation sequencing instruments. Under the agreement, GenDx and its distributors will have the rights to offer an end to end workflow to Human Leukocyte Antigen (HLA) typing laboratories that includes the Ion Torrent brand of next-generation sequencing (NGS) systems and consumables with GenDx assays and analysis software for allelic level HLA typing analyses.
Some of the other key players in the global market include Illumina, Inc, Pacific Biosciences of California, Inc., Siemens AG, ZS Genetics, Inc, Abbott Laboratories, Li-Cor, Inc., F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies, and Agilent Technologies, Inc.
DNA Sequencing Market Segmentation
By End User